Who is sponsoring NCT03730597?

NCT03730597 is sponsored by Hospital del Mar.

What drugs are being tested in NCT03730597?

Interventions in NCT03730597: reverse shoulder arthroplasty.

What condition does NCT03730597 study?

NCT03730597 studies Total Shoulder Arthroplasty.

Is NCT03730597 still recruiting?

NCT03730597 is currently completed. Last updated 12 March 2019.

Last reviewed 2019-03-12 · How we verify

NCT03730597: GSSNRSA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Glenosphere Size and Scapular Notch in RSA, Prospective Randomized Study

Completed NA Last updated 12 March 2019

What this trial tests

NA trial testing reverse shoulder arthroplasty in Total Shoulder Arthroplasty in 95 participants. Completed in 9 September 2016.

Timeline

1 September 2014

Primary endpoint
9 September 2016

9 September 2016

Quick facts

Lead sponsor	Hospital del Mar
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	95
Start date	1 September 2014
Primary completion	9 September 2016
Estimated completion	9 September 2016

Drugs / interventions tested

reverse shoulder arthroplasty

Conditions studied

Total Shoulder Arthroplasty — all drugs for Total Shoulder Arthroplasty →

Sponsor

Hospital del Mar

Who can join

Eligibility, any sex, with Total Shoulder Arthroplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Scapular notch can be reduced by using bigger glenospheres but in some patients it cannot be implanted because of small size. If small size of glenosphere is used then scapular notch may increase. To improve that situation, eccentricity has been added to some glenospheres to increase glenoid overhanging. The objective is to assess if eccentricity can avoid scapular notch as effectively as bigger glenospheres.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Shoulder replacement surgery for osteoarthritis and rotator cuff tear arthropathy.
Craig RS, Goodier H, Singh JA, Hopewell S, et al · · 2020 · cited 34× · PMID 32315453 · DOI 10.1002/14651858.cd012879.pub2

Verify or expand the search:

Other trials of reverse shoulder arthroplasty

Trials testing the same drug.

NCT06382779 — Proximal Humerus Reconstruction After Resection for Tumors : Comparison Between Allograft Prosthetic Composite and Cemen · enrolling by invitation
NCT05847062 — Clinical Trial to Analyze Lateralized Models and Medializations of Inverted Arthroplasty. · NA · unknown
NCT04762667 — Individual Preoperative Planning for RSA · NA · unknown

Other recruiting trials for Total Shoulder Arthroplasty

Currently open trials in the same condition.

NCT06143306 — Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement · Phase 4 · recruiting
NCT05900427 — Effects on Postoperative Pain of Liposomal Bupivacaine in Interscalene Blocks for Total Shoulder Arthroplasty Patients · Phase 4 · recruiting

Other Hospital del Mar trials

Trials by the same sponsor.

NCT07481760 — Acute Cholecystitis Biliary Complications - ICG · NA · not yet recruiting
NCT07208994 — Pathways to Equitable Access to Kidney Transplantation in Spain: A Transformative Mixed-methods Study Protocol · not yet recruiting
NCT06981273 — Robotic vs Open Pancreatoduodenectomy · NA · not yet recruiting
NCT06765044 — Textbook Outcomes in Urgent Appendectomy · not yet recruiting
NCT06228027 — External Validation os the ACME Scoring System · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03730597 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital del Mar
Last refreshed: 12 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03730597.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing